generics

FDA Withdraws Proposed Rule on Generic Label Changes
FDA Withdraws Proposed Rule on Generic Label Changes
RAPS.org
FDA
labeling
generics
Flag link:
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Flag link:
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Stat
Kaleo
opioids
opioid addiction
generics
Naloxone
Evzio
opioid overdose
Flag link:
Investigation of generic ‘cartel’ expands to 300 drugs
Investigation of generic ‘cartel’ expands to 300 drugs
Washington Post, DC
generics
price fixing
Flag link:
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Flag link:
Mallinckrodt splitting into 2 with generic spin-off plan
Mallinckrodt splitting into 2 with generic spin-off plan
BioPharma Dive
Mallinckrodt
generics
spinoffs
Flag link:
Generic Drug Prices ‘Strongly Predictive’ of Shortages, Study Finds
Generic Drug Prices ‘Strongly Predictive’ of Shortages, Study Finds
RAPS.org
generics
drug shortages
drug pricing
Flag link:
Teva launches EpiPen generic at same price as Mylan's version
Teva launches EpiPen generic at same price as Mylan's version
Biopharma Dive
Teva Pharmaceutical
Mylan
EpiPens
generics
Flag link:
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Fierce Pharma
JNJ
generics
Zytiga
Supreme Court
patents
Flag link:
J&J shares fall after court refuses to block Zytiga generics
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
JNJ
generics
Zytiga
prostate cancer
Flag link:
White House Report Shows Increase in Generics Competition Saved Americans $26 Billion
White House Report Shows Increase in Generics Competition Saved Americans $26 Billion
BioSpace
generics
Flag link:
Healthcare Spending on Branded Prescription Drugs Continues to Rise Despite Availability of More Generics
Healthcare Spending on Branded Prescription Drugs Continues to Rise Despite Availability of More Generics
Xtalks
generics
branded pharma
drug spending
Flag link:
Novartis 'completely committed' to Sandoz, has no split-off plan
Novartis 'completely committed' to Sandoz, has no split-off plan
Yahoo/Reuters
Novartis
Sandoz
generics
Flag link:
Specialty Generics: Barriers To Uptake
Specialty Generics: Barriers To Uptake
Forbes
generics
Flag link:
FDA Hits Monthly Generic Drug Approval Record in October
FDA Hits Monthly Generic Drug Approval Record in October
RAPS.org
FDA
drug approvals
generics
Flag link:
Generic arthritis drug comes up short against inflammation in heart disease
Generic arthritis drug comes up short against inflammation in heart disease
Stat
generics
rheumatoid arthritis
methotrexate
Flag link:
Allergan nixes Texas plant expansion as Restasis generics loom
Allergan nixes Texas plant expansion as Restasis generics loom
Fierce Pharma
Allergan
drug manufacturing
Restasis
generics
Flag link:
Zytiga generics looming as US court nixes J&J patent
Zytiga generics looming as US court nixes J&J patent
Pharmaforum
JNJ
Zytiga
generics
prostate cancer
Flag link:
FDA offers a proposal to help generic drug developers get simultaneous approvals in multiple markets
FDA offers a proposal to help generic drug developers get simultaneous approvals in multiple markets
Endpoints
FDA
generics
drug development
Flag link:
FDA sets record for number of generic drug approvals again
FDA sets record for number of generic drug approvals again
Endpoints
FDA
generics
drug approvals
Flag link:

Pages